EXC analyst estimates
Exelon (EXC) analyst ratings, the average price target and its range, and every firm's latest call.
EXC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 19, 2026 | Barclays | Exelon price target lowered to $44 from $49 at Barclays | $44.00 |
| Sep 22, 2026 | Argus Research | Exelon (EXC) PT Lowered to $49 at Argus | $49.00 |
| Sep 18, 2026 | Morgan Stanley | Exelon price target lowered to $50 from $53 at Morgan Stanley | $50.00 |
| Aug 13, 2026 | Truist Financial | Exelon price target lowered to $48 from $50 at Truist | $48.00 |
| May 29, 2026 | Truist Financial | Exelon price target lowered to $49 from $50 at Truist | $49.00 |
| May 13, 2026 | KeyBanc | Exelon price target lowered to $41 from $43 at KeyBanc | $41.00 |
| Apr 21, 2026 | Wells Fargo | Exelon price target lowered to $50 from $53 at Wells Fargo | $50.00 |
| Apr 21, 2026 | KeyBanc | Exelon price target lowered to $43 from $44 at KeyBanc | $43.00 |
| Apr 21, 2026 | Morgan Stanley | Exelon price target lowered to $55 from $56 at Morgan Stanley | $55.00 |
| Apr 20, 2026 | Jefferies | Jefferies downgrades Exelon to Hold on legislative pressures | $50.00 |
| Apr 20, 2026 | RBC Capital | Exelon price target lowered to $48 from $51 at RBC Capital | $48.00 |
| Apr 20, 2026 | Truist Financial | Exelon initiated with a Hold at Truist | $50.00 |
| Apr 17, 2026 | BMO Capital | Exelon downgraded to Equal Weight from Overweight at Barclays | $49.00 |
| Apr 17, 2026 | Mizuho Securities | Exelon downgraded to Neutral from Outperform at Mizuho | $48.00 |
| Feb 20, 2026 | UBS | Exelon price target raised to $51 from $48 at UBS | $51.00 |
- 17 firms rate EXC: 5 buy, 12 hold, 0 sell.
- The average price target is $46.40 from 5 analysts, from $41.00 to $50.00.
Updated 2026-11-02 17:51 UTC